Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271463 · ClinicalTrials.gov registry record
Assessing Leg Control in People With Chronic Stroke
A clinical trial of Chronic Stroke, sponsored by University of Minnesota.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT03271463: Completed study of Chronic Stroke, sponsored by University of Minnesota.
NCT03271463 is a study of Chronic Stroke that has completed, run by University of Minnesota. The registered enrollment target is 16 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03271463, a study of Chronic Stroke, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the clinometric (psychometric) properties of the SCALE and FMA-LE assessments in adults after stroke. A second purpose is to determine how well each measure predicts walking speed using the 10 meter walk test.
Primary Outcome
Each item is rated 2-0, 2 being Normal and 0 being Unable to Move
Conditions Studied
Interventions
- BEHAVIORAL Selective Control Assessment of Lower Extremity (SCALE)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-08-05 |
| Est. Completion | 2020-11-05 |
What the finished NCT03271463 record still lists
NCT03271463 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Selective Control Assessment of Lower Extremity (SCALE) is the first listed.
NCT03271463 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03271463 about?
NCT03271463 is a clinical study titled "Assessing Leg Control in People With Chronic Stroke". The purpose of this study is to compare the clinometric (psychometric) properties of the SCALE and FMA-LE assessments in adults after stroke. A second purpose is to determine how well each measure predicts walking speed using the 10 meter walk test.
What is the current status of trial NCT03271463?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2018-08-05. Estimated completion is 2020-11-05.
What conditions does trial NCT03271463 study?
This clinical trial studies the following conditions: Chronic Stroke.
What interventions are being tested in trial NCT03271463?
The interventions under investigation include: Selective Control Assessment of Lower Extremity (SCALE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03271463?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03271463 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03271463's enrollment target sits among peer trials
16 16th of 20 higher than 5 of 20 other Chronic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
Effect of NMES on Balance and Fall Risk in Chronic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation Mechanisms
RECRUITING · NA
-
Home-based FES Training in People With Chronic Stroke
RECRUITING · NA
-
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI